ALL
Clinical trials for ALL explained in plain language.
Never miss a new study
Get alerted when new ALL trials appear
Sign up with your email to follow new studies for ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gentler transplant prep aims to cure tough blood cancers
Cure CompletedResearchers test a reduced-intensity conditioning regimen before allogeneic stem cell transplant in adults with high-risk AML, MDS, or ALL who cannot tolerate standard intensive treatment. The regimen combines clofarabine, busulfan, and thymoglobulin. The trial measures relapse r…
Matched conditions: ALL
Phase 2 • Sponsor: Nantes University Hospital • Aim: Cure
Last updated Sep 16, 2026 00:00 UTC
-
Engineered immune cells show promise against tough childhood cancers
Disease control CompletedThis phase 1 trial tested a new therapy called CD22-CAR T cells in 134 children and young adults (ages 1-39) with B-cell leukemia or lymphoma that had not been cured by standard treatments. The therapy involves taking a patient's own white blood cells, modifying them in a lab to …
Matched conditions: ALL
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Ashwagandha under the microscope: 12-Month safety check for popular herb
Knowledge-focused CompletedThis study followed 200 adults aged 18 to 65 who were already taking the herbal supplement KSM-66 ashwagandha as prescribed by their doctor. The main goal was to check for any side effects over a full year, with a focus on liver health. Researchers also looked at whether the supp…
Matched conditions: ALL
Sponsor: SF Research Institute, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC